WST R&D to Revenue

West Pharmaceutical Services · R&D to Revenue

WST logo

WST R&D to Revenue

Latest reported2.42%
WST FY R&D/Revenue (0.00% → 2.42%)
High-resolution chart · PNG

WST r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
2.4173%
2.3888%
2.3178%
2.0274%
1.8653%
2.1847%
2.11%
2.3458%
2.4434%
2.4385%
2.4392%
2.6236%
2.7701%
2.6216%
2.44%
2.1635%
1.885%
1.7791%
1.5783%
1.2154%
1.1291%
1.1632%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.